Anhui Huangshan Capsule Co., Ltd.

Equities

002817

CNE100002BV5

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
6.37 CNY +0.79% Intraday chart for Anhui Huangshan Capsule Co., Ltd. +3.92% -27.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Anhui Huangshan Capsule Co., Ltd. Announces Final Cash Dividend of A Shares for 2022, Payable on 07 June 2023 CI
Anhui Huangshan Capsule Co., Ltd. Approves 2022 Profit Distribution Plan CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Anhui Huangshan Capsule Posts 12% Rise in 2022 Profit MT
Anhui Huangshan Capsule Co., Ltd. Approves Board Elections CI
Shandong Lutai Holding Group Co., Ltd. completed the acquisition of a 29.99% stake in Anhui Huangshan Capsule Co., Ltd. from Yu Chunming. CI
Shandong Lutai Holding Group Co Ltd completed the acquisition of a 30% stake in Anhui Huangshan Capsule Co., Ltd.. CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Anhui Huangshan Capsule Discloses Change in Controlling Shareholder MT
Shandong Lutai Holding Group Co Ltd agreed to acquire a 30% stake in Anhui Huangshan Capsule Co., Ltd. for CNY 1.1 billion. CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Anhui Huangshan Capsule Co., Ltd. Announces Final Cash Dividend for the Year 2021 CI
Anhui Huangshan Capsule Bumps 2021 Dividend by 33% on Robust Earnings MT
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Anhui Huangshan Capsule Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 09 June 2021 CI
Anhui Huangshan Capsule Co., Ltd. Approves Final Cash Dividend for the Year 2020 CI
Anhui Huangshan Capsule Co., Ltd. Proposes Final Cash Dividend for the Year 2020 CI
Zhongyuanfang Industrial Co., Ltd. signed an agreement to acquire 29.99% stake in Anhui Huangshan Capsule Co., Ltd. from Yu Chunming. CI
Anhui Huangshan Capsule Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Chart Anhui Huangshan Capsule Co., Ltd.
More charts
Anhui Huangshan Capsule Co Ltd is a China-based company principally engaged in the manufacture and sales of hollow medical capsules. The Company's products mainly include gelatin hollow capsules and enteric gelatin hollow capsules. The Company is also engaged in the manufacture and sales of pharmaceutical equipment. The Company mainly distributes its products within domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 002817 Stock
  4. News Anhui Huangshan Capsule Co., Ltd.
  5. Anhui Huangshan Capsule Bumps 2021 Dividend by 33% on Robust Earnings